Johnson & Johnson (JNJ.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec18

Johnson & Johnson Medical Devices Receives FDA Approval for TRUFILL n-BCA for Chronic Subdural Hematoma

13:01

Dec17

FDA Approves Johnson & Johnson's RYBREVANT FASPRO for EGFR-Mutated Non-Small Cell Lung Cancer

23:21

RBC Raises Johnson & Johnson's Target Price to $240

04:32

Dec15

Bank of America Raises Johnson & Johnson's Target Price to $220

18:27

US FDA Grants Priority Review Voucher to Johnson & Johnson for Blood Cancer Treatment

15:31

Johnson & Johnson's Prostate Cancer Therapy Akeega Receives FDA Approval

09:36

Schedules & Filings

Schedules

Filings

Jan21

Earning Release(EST)

FY2025 Q4 Earning Release

Dec9

Distribution Plan(EST)

Cash dividend 1.3 USD

Nov25

Distribution Plan(EST)

Cash dividend 1.3 USD

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More